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Protein kinase A is activated by the n–3 polyunsaturated
fatty acid eicosapentaenoic acid in rat ventricular muscle
Norbert Szentandra´ssy1, M. R. Pe´rez-Bido2, E. Alonzo3, N. Negretti2 and Stephen C. O’Neill1
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During cardiac ischaemia antiarrhythmic n–3 polyunsaturated fatty acids (PUFAs) are released
following activation of phospholipase A2, if they are in the diet prior to ischaemia. Here
we show a positive lusitropic effect of one such PUFA, eicosapentaenoic acid (EPA) in the
antiarrhythmic concentration range in Langendorff hearts and isolated rat ventricular myocytes
due to activation of protein kinase A (PKA). Several different approaches indicated activation of
PKA by EPA (5–10μmol l−1): the time constant of decay of the systolic Ca2+ transient decreased
to 65.3 ± 5.0% of control, Western blot analysis showed a fourfold increase in phospholamban
phosphorylation, and PKA activity increased by 21.0 ± 7.3%. In addition myofilament Ca2+
sensitivity was reduced in EPA; this too may have resulted from PKA activation. We also found
that EPA inhibited L-type Ca2+ current by 38.7 ± 3.9% but this increased to 63.3 ± 3.4% in
10μmol l−1 H89 (to inhibit PKA), providing further evidence of activation of PKA by EPA.
PKA inhibition also prevented the lusitropic effect of EPA on the systolic Ca2+ transient and
contraction. Our measurements show, however, PKA activation in EPA cannot be explained
by increased cAMP levels and alternative mechanisms for PKA activation are discussed. The
combined lusitropic effect and inhibition of contraction by EPA may, respectively, combat
diastolic dysfunction in ischaemic cardiac muscle and promote cell survival by preserving
ATP. This is a further level of protection for the heart in addition to the well-documented
antiarrhythmic qualities of these fatty acids.
(Resubmitted 19 March 2007; accepted after revision 10 May 2007; first published online 17 May 2007)
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Fatty acids are released in cardiac muscle during
periods of ischaemia due to stress-induced activation of
phospholipase A2 (PLA2) (Ford et al. 1991; Hazen et al.
1991; McHowat et al. 1998). The kind of fatty acid released
depends ultimately on their presence in the diet. A diet rich
in fish oils leads to incorporation of n–3 polyunsaturated
fatty acids (PUFAs) into the phospholipid substrate for
PLA2 and their subsequent release during ischaemia (Nair
et al. 1999), and also reduces the risk of cardiovascular
disease. Following myocardial infarct, one oily fish meal
per week reduces the risk of a second cardiac event by up
to 50% (Kris-Etherton et al. 2002). It is thought this is
due, at least in part, to antiarrhythmic properties of n–3
PUFAs. These fatty acids reduce electrical excitability of
the cell (Kang et al. 1995). It has been shown that Na+
current (Xiao et al. 1995, 2001), L-type Ca2+ current
(Xiao et al. 1997; Negretti et al. 2000) and transient
outward current (Macleod et al. 1998) are inhibited by
micromolar concentrations of the n–3 PUFA
eicosapentaenoic acid (EPA), resulting in reduced
electrical excitability. In addition, many arrhythmias are
thought to result from spontaneous Ca2+ release from
the sarcoplasmic reticulum (SR) and the consequent
activation of Na+–Ca2+ exchange (Capogrossi et al. 1987).
This produces depolarising current that may trigger
an action potential. The n–3 PUFAs also inhibit the
mechanism responsible for SR Ca2+ release (Negretti et al.
2000) via direct inhibition of the release channel (Swan
et al. 2003). Thus, one of the mechanisms for producing
spontaneous action potentials is reduced in frequency
and a larger trigger is required.
n–3 PUFAs ought also to have effects via intracellular
signalling pathways that can alter cardiac contractility
and affect diastolic function in ischaemic hearts. Many
protein kinases are inhibited by n–3 PUFAs, e.g.
calmodulin-dependent protein kinase (CaM kinase II),
protein kinase C (PKC), MAPK as well as protein kinase A
(PKA) (Mirnikjoo et al. 2001). However, the case with
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PKA is complicated as phosphodiesterase is also inhibited,
allowing cAMP levels to rise (Picq et al. 1996). Given this,
it is difficult to predict whether PKA will be activated or
inhibited. In the context of myocardial ischaemia, however,
the contractile function of the heart is compromised,
leading to diastolic dysfunction. Any changes in PKA
activity, and e.g. phospholamban phosphorylation, would
clearly be of importance to the degree of diastolic
dysfunction.
Here, we report experiments that show activation of the
PKA pathway by application of the n–3 PUFA EPA. We
propose this may have two beneficial effects: (i) a positive
lusitropic effect will help to reduce diastolic dysfunction
during ischaemia, and (ii) a reduction of myofilament
Ca2+ sensitivity may promote cell survival in ischaemia by
preserving ATP.
Methods
Rat ventricular myocytes were isolated using a collagenase
and protease technique as previously described (Eisner
et al. 1989). Adult male Wistar rats were killed by
stunning and cervical dislocation. For intracellular
Ca2+ measurements, cells were loaded with the
membrane-permeant form of Indo-1 at 5 μmol l−1
for 10 min; a period of 20 min was allowed for
de-esterification. Cells were placed in a superfusion
chamber on the stage of an inverted microscope.
Indo-1 fluorescence was excited at 360 nm, and recorded
at 400 and 500 nm (O’Neill & Eisner, 1990) using
epi-fluorescence optics. All voltage- and current-clamp
experiments were carried out with the perforated
patch-clamp technique (Horn & Marty, 1988) and
voltage-clamp experiments used the switch-clamp mode
of the Axoclamp 2A amplifier (Axon Instruments).
Pipettes were filled with the following solution (mmol l−1):
KCH3O3S, 125; KCl, 20; NaCl, 10; Hepes, 10; MgCl2, 5;
K2EGTA, 0.1; titrated to pH 7.2 with KOH, and a final
concentration of amphotericin B of 240 μg ml−1.
The bathing solution was as follows (mmol l−1): NaCl,
134; KCl, 4; Hepes, 10; glucose, 11; MgCl2, 1; CaCl2, 1;
titrated to pH 7.4 with NaOH. Solutions with 50% Na+
content had 67 mm N-methyl-d-glucamine added to
replace Na+. EPA was prepared in ethanol as a 33 mmol l−1
stock solution and stored under a N2 atmosphere for
up to 1 week. Fatty-acid-free bovine serum albumin was
added (2 mg ml−1) to the washout solution to ensure rapid
and complete removal of fatty acid from the solution
(Kang & Leaf, 1994; Kang et al. 1995). In voltage-clamp
experiments, the holding potential was −40 mV and
cells were depolarized for 200 ms to 0 mV at 0.5 Hz, the
bathing solution contained 5 mmol l−1 4-aminopyridine
and 0.1 mmol l−1 BaCl2 to inhibit outward currents. The
use of H89 caused a substantial reduction in the L-type
Ca2+ current, to retain a large enough current for analysis,
we raised external Ca2+ to 3 mmol l−1.
Preparation of cardiac tissue for PKA assay
and cAMP measurements
Langendorff hearts were perfused with the solution
(mmol l−1): NaCl, 134; KCl, 4; Hepes, 10; glucose, 11;
MgCl2, 1.2; CaCl2, 1; titrated to pH 7.4 with NaOH, used
as control. Hearts were perfused with control solution,
EPA (10 μmol l−1) or isoprenaline (1 μmol l−1) at 37◦C.
Left ventricular pressure was measured using a balloon
in the left ventricle attached to a pressure transducer,
the frequency was set at 4 Hz by stimulating electrodes
in the left ventricular wall. After 20 min perfusion
(sufficient for the positive lusitropic effect of EPA and
isoprenaline to be observed) tissue was taken for PKA and
cAMP determinations. (1) 1 g of heart tissue was homo-
genized in 5 ml of cold extraction buffer (25 mmol l−1 Tris
HCl at pH 7.4, 0.5 mmol l−1 EDTA, 0.5 mmol l−1 EGTA,
10 mmol l−1 β-mercaptoethanol, 1 μg ml−1 leupeptin,
1 μg ml−1 aprotinin, 200 mmol l−1 phenylmethylsulfonyl
fluoride (PMSF)).The lysate was centrifuged for 5 min
at 600 g (4◦C) and the supernatant saved. The super-
natant was taken and PKA activity was determined
by a spectrophotometric assay (Roskoski, 1983). (2)
Heart tissue was cut in fine pieces; weighed and 10 μl
of 3-isobutyl-1-methylxanthine (IBMX; 100 μm) was
added. Heart samples were frozen in liquid nitrogen.
Frozen samples were ground to a fine powder and
homogenized in 10 vol. 0.1 m HCl, centrifuged at 600 g and
assayed immediately. cAMP was measured using a direct
cyclic AMP enzyme immunoassay kit (Assay Designs). A
standard cAMP curve was fitted using a four-parameter
logistic equation (Sigmaplot 10 program).
Tissue preparation for Western blots
SR vesicles were isolated from tissue harvested as above
for Western blot analysis (Korge & Campbell, 1995). SR
preparation was lysed in 150 μl of ice-cold RIPA buffer (1×
PBS, 1% Igepal, 0.5% sodium deoxycholate, 0.1% SDS)
with freshly added protease and phosphatase inhibitors
(100 μg ml−1 PMSF, 10 μg ml−1 aprotinin, 2 mmol l−1
sodium orthovanadate), incubated on ice for 30 min and
centrifuged at 15 000 g for 20 min at 4◦C.
Total protein concentrations were measured by
Bradford’s method. Whole cell lysate (60 μg) was added to
10 μl of 5× electrophoresis sample buffer and separated by
SDS/PAGE under reducing conditions on a 15% separation
gel with a 4% stacking gel in a Miniprotean II camera
(Bio-Rad).
Proteins were electrophoretically transferred to
nitrocellulose membrane (16 h, 4◦C). Unspecific binding
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Table 1. Developed pressure and rate constants of relaxation measured in Langendorff-perfused
hearts in control and EPA (10 μM; n = 10) or isoprenaline (1 μM; n = 5)
Control EPA Control Isoprenaline
Developed pressure (mmHg) 90.2 ± 6.3 120.7 ± 9.9∗∗ 65.5 ± 6.0 103.1 ± 11.7∗∗
Rate constant (s−1) 14.2 ± 2.2 21.5 ± 2.0∗ 20.3 ± 1.5 34.5 ± 2.7∗
∗P < 0.015, ∗∗P < 0.02.
was blocked by incubation in Blotto buffer (1×TBS,
5% nonfat milk and 0.05% Tween 20). Proteins in the
membrane were then immunoblotted with antibodies
Anti-Phospholamban Phospho-Specific (Ser16;
Calbiochem), according to the manufacturer’s
protocols.
Blots were incubated in a chemiluminescence reagent
(Pierce) according to data sheet and exposed to a K-Omat
X-ray film (Kodak). The densities of the bands were
evaluated using Quantity One software in a G-800
Densitometer (Bio-Rad).
All experiments in the UK were done at room
temperature (25◦C) and in accordance with the Animal
Scientific Procedures Act (1986). All experiments in
Venezuela were done according to guidelines of the
Universidad Central de Venezuela. All statistics quoted
are means ± s.e.m. Student’s t tests (one- and two-tailed,
where appropriate) were used to test significance.
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Figure 1. Eicosapentaenoic acid (EPA)
increases the rate of relaxation of field
stimulated cardiac myocytes
A, slow timebase record of field stimulated cell
shortening from a single rat ventricular
myocyte, EPA (10 μmol l−1) was applied as
indicated by the bar. B, averaged records from
A for the times indicated by letters (n = 5);
these are shown normalized for amplitude and
superimposed below.
Results
The lusitropic effect of EPA is shown in Fig. 1. Figure 1A
shows a slow timebase cell length record of a single
ventricular myocyte under field stimulation. As EPA
(10 μmol l−1) washes in cell contraction amplitude
increases, longer exposures to EPA lead to a decline in
amplitude (not shown). Towards the end of the record
contraction fails several times indicating reduced electrical
excitability of the cell (Kang et al. 1995). In Fig. 1B,
averaged records (n = 5) are shown from points indicated
by the letters, when these are normalized and superim-
posed below it is clear that cell relaxation becomes faster
in EPA. The remaining experiments in this paper were
designed to investigate the possible role of PKA in this
positive lusitropic effect of EPA.
We firstly examined the effect of EPA on the Ca2+
transient responsible for contraction. Figure 2 shows an
experiment under current-clamp conditions. The upper
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Figure 2. EPA increases the amplitude and rate of
fall of the systolic Ca2+ transient
A, averaged Indo-1 fluorescence ratios before, during
and after EPA (5 μmol l−1) application (n = 10). Below
control and EPA records are shown normalized for
amplitude and superimposed. B, current-clamp records
showing averaged action potentials (n = 10) in control
and in EPA (•).
Figure 3. EPA accelerates relaxation, raises phospholamban
phosphorylation and increases PKA activity
A, left ventricular developed pressure under control conditions (top)
and in 10 μmol l−1 EPA. B, typical Western blot of phospholamban
phosphorylated at Ser16 from SR vesicles isolated from different hearts
perfused with Tyrode solution (control), EPA 10 μmol l−1 or
isoprenaline (Iso; 1 μmol l−1). Mean band intensities are: for control,
7.4 ± 2.2 densitometric units (μg protein)−1 (n = 7); EPA, 32.8 ± 8.8
(10 μM; P < 0.01, n = 10); and isoprenaline, 89.9 ± 12.5 (1 μM;
P < 0.01, n = 3). C, time-dependent reduction in NADH absorbance
as PKA releases ADP in control (), in EPA (10 μmol l−1, ) and
isoprenaline (1 μmol l−1, ).
part of Fig. 2A shows Ca2+ transients obtained in control,
EPA (5 μmol l−1) and after washout. There is a clear
reversible increase of Ca2+ transient amplitude. It is also
clear from the normalized and superimposed traces that
in EPA the transient falls more rapidly. The time constant
of decay decreased to 65.3 ± 5.0% of control (P < 0.0001,
n = 10). In Fig. 2B, action potentials measured at the same
time as the Ca2+ transients are shown superimposed.
As has been shown previously (Macleod et al. 1998),
EPA increases action potential duration. This is probably
responsible for the increased Ca2+ transient amplitude,
but seems unlikely to cause a faster fall of Ca2+.
One explanation for the faster fall of Ca2+ is
activation of PKA, phosphorylation of phospholamban
and greater activation of the SR Ca2+ ATPase (SERCA). To
determine whether this is so we applied EPA (10 μmol l−1)
to Langendorff-perfused hearts. Figure 3A shows left
ventricular developed pressure in control (left) and in EPA
(right). The developed pressure is greater and falls faster
in EPA; this was seen in all 10 hearts studied. (See Table 1)
If PKA is activated in EPA, phosphorylation of
phospholamban may be increased, accelerating SR
Ca2+ uptake. To establish whether EPA induces
phosphorylation of phospholamban by PKA, we
determined phospholamban phosphorylation at Ser16 (the
PKA specific site) by Western blot analysis in cardiac
vesicles from hearts treated with Tyrode solution (control),
EPA or isoprenaline.
The Western blot in Fig. 3B shows that phosphorylation
of phospholamban at Ser16 in SR vesicles increases
in EPA and in 1 μmol l−1 isoprenaline (positive
control). In control, tissue band density was
7.4 ± 2.2 densitometric units μg−1 protein (n = 7); in
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EPA it was 32.8 ± 8.8 (n = 10, P < 0.01). In isoprenaline,
the average density was 89.9 ± 12.5 (n = 3, P < 0.01).
We decided to determine and compare PKA activity
in rat hearts in control and after perfusion with EPA
once the lusitropic effect developed, using isoprenaline
as a positive control in other hearts. A typical example
of records obtained for PKA activity is shown in Fig. 3C;
both EPA and isoprenaline increased the rate of fall of
absorbance in the PKA assay. On average, EPA increased
PKA activity by 21.0 ± 7.3% (P = 0.016; n = 11), and
activity was increased in isoprenaline by 21.1 ± 9.1%
(P = 0.042; n = 11). The control test showed an average
activity for PKA of 244 ± 41.3 UI (mg protein)−1 (n = 11).
With such an increase of PKA activity we would expect
there also to be an increase of cAMP therefore we set out
to measure [cAMP] in the same tissue samples used in
Fig. 3C. The values measured were 60.4 ± 7.9 pmol ml−1
(n = 14) in the control, 33.0 ± 5.0 pmol ml−1 (P < 0.01;
n = 17) in EPA, and 90.9 ± 14.0 pmol ml−1 (P < 0.02;
n = 10) in isoprenaline.
If EPA does indeed activate PKA we should be able
to measure other effects of PKA, e.g. an increase of
L-type Ca2+ current. Previous work has shown that EPA
inhibits L-type Ca2+ channels (Xiao et al. 1997; Negretti
et al. 2000) but if EPA also activates PKA leading to
more L-type current, the extent of inhibition would
appear reduced. In Fig. 4A we see inhibition of L-type
current by 5 μmol l−1 EPA; current was reduced by
38.7 ± 3.9% (n = 18). Repeating this in 10 μmol l−1 H89,
to inhibit PKA, current inhibition by EPA significantly
increased to 63.3 ± 3.4% (n = 12, P < 0.00005). In H89
we raised external Ca2+ to 3 mmol l−1 to compensate for
the reduction of L-type current (the current fell in H89 by
H89
 
 
50 ms
50
0 
pA
 
 
 
 
Control EPA Washout
50 ms
50
0 
pA
A
B
Figure 4. L-type Ca2+ current inhibition by EPA is
increased in the presence of H89
A, averaged voltage-clamped (stepping from −40 to
0 mV for 200 ms) L-type Ca2+ current records (n = 10)
in control, EPA (5 μmol l−1) and after washout with
BSA (1 mg ml−1). B, L-type Ca2+ current records in
control (n = 12), EPA (5 μmol l−1) and after washout in
the presence of 10 μmol l−1 H89 throughout.
72.7 ± 0.8%, n = 2). This extra EPA-dependent inhibition
in H89 indicates that activation of PKA by EPA, indeed,
increases L-type Ca2+ current.
In the course of these experiments an interesting
anomaly came to light. The Ca2+ measurements in Fig. 2
were made under current clamp. The data in Fig. 5 are
systolic Ca2+ transients stimulated by voltage-clamp pulses
from −40 to 0 mV for 200 ms. We have shown that EPA
reduces contraction amplitude in voltage-clamped rat
ventricular myocytes (Negretti et al. 2000) and the Ca2+
transients in Fig. 5A are smaller as expected. However, the
superimposed transients after normalization show below
that in EPA the fall of the Ca2+ transient is actually slower;
the time constant of decay increased by 13.4 ± 3.6%
(P < 0.002, n = 23). This does not agree with the effect
of EPA on the Ca2+ transient shown in Fig. 2. We should
note, however, that the Ca2+ transient amplitude increases
under current-clamp or field stimulation but decreases in
voltage clamp. We have attempted to take such changes
into account in Fig. 5B.
The data in Fig. 5B show the relationship between the
amplitude of the Ca2+ transient and its time constant of
decay. The Ca2+ transient amplitude was varied under
voltage clamp by changing the depolarising pulse size.
As expected, under control conditions (filled circles)
larger transients relax more quickly (Schouten, 1990;
Bassani et al. 1995). In 5 μmol l−1 EPA in the same
cells as in the control, the curve shifts to shorter time
constants at all Ca2+ transient amplitudes. The slopes of
the linear regression lines fitted to the raw data (not shown)
are different between control and in EPA (P < 0.002)
and the time constant of decay is smaller in EPA
(P < 1 × 10−6).
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Repeating this experiment in H89 to inhibit PKA (open
and filled squares represent EPA and control, respectively,
in H89) EPA no longer shifts the relationship (P > 0.09);
we conclude therefore that the separation in the absence of
H89 is due to phosphorylation of phospholamban by PKA.
It is also worth noting that H89 alone causes a substantial
shift of the curves to longer time constants of decay. This,
in addition to the reduction of L-type Ca2+ current by
H89, indicates that under normal conditions there is a
resting level of PKA activity (also shown in Fig. 3B) that is
inhibited by H89.
As mentioned before, under voltage-clamp EPA leads
to a slower decay of the Ca2+ transient (Fig. 5A). The
experiment in Fig. 6, however, shows, the cell still relaxes
faster; in the upper panel, three averaged contractions
are shown under voltage clamp. The amplitude is clearly
reduced by application of EPA (5 μmol l−1); however,
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Figure 5. The effect of EPA on the time constant of decay of
systolic Ca2+ transient in voltage-clamped cells
A, averaged records (n = 10) of systolic Ca2+ transients stimulated by
depolarising from −40 to 0 mV for 200 ms. Control and EPA
(5 μmol l−1) transients are normalized for amplitude and
superimposed below. B, time constant of systolic Ca2+ transient as a
function of amplitude. •, The time constant of the fall of Ca2+
decreases as amplitude increases. , The effect of EPA. The effect of
EPA is lost when H89 (10 μmol l−1) is present (, EPA; , EPA and
control; in H89).
normalization shows that time to peak and relaxation are
faster in EPA. Due to the complicated shape of contraction,
we could not fit exponentials, so to quantify this effect of
EPA we normalized contraction amplitude and calculated
the area under the curve. Briefer contractions will have a
smaller area, although the increased rate of relaxation will
be underestimated due to the more rapid rate of rise of
contraction in EPA. On average, this integral decreased to
78.2 ± 8.4% of control (P < 0.05, n = 6). This suggests an
additional effect of EPA on the contractile filaments, as
faster relaxation results in spite of a slower fall of Ca2+.
A positive lusitropic effect like that in Fig. 6 should
also be sensitive to PKA inhibition. In Fig. 7A, we show
the positive lusitropic effect on contraction of EPA in a
field-stimulated cell. The increased rate of rise and fall of
contraction is clear when control and EPA contractions
are normalized and superimposed (below). In Fig. 7B, this
protocol is repeated in 10 μmol l−1 H89 to inhibit PKA.
As with L-type Ca2+ current (Fig. 4), the contraction is
smaller in H89 and EPA inhibits the amplitude further.
However, the superimposed traces below show the rates
of rise and fall of contraction are no longer affected
by EPA. We have quantified this as described above.
On average, the contraction integral in EPA alone was
reduced to 64.7 ± 2.7% of control (P < 0.0001, n = 6). In
H89, EPA produced no significant change, the integral
being 103.5 ± 3.1% of that in H89 alone (P > 0.35).
We conclude, therefore, that any effect of EPA on the
SR or myofilaments has been prevented by inhibiting
PKA.
The results of Figs 5A and 6 showing the effect on Ca2+
transients and contractions suggest that myofilament Ca2+
sensitivity is altered in EPA. To demonstrate this, cells were
preincubated in ryanodine (1 μmol l−1) to inhibit the SR,
and external Na+ was then reduced by 50% to induce an
influx of Ca2+ on Na+−Ca2+ exchange. In the left panel
of Fig. 8A is the rise of Ca2+ produced by lowering Na+
(signalled by the rise in the Indo-1 ratio) and the resulting
contraction above.
When this protocol was repeated after 3 min in
10 μmol l−1 EPA, the same rise of Ca2+ produces much less
contraction, i.e. myofilament sensitivity to Ca2+ is reduced.
The plot in Fig. 8B of cell length as a function of the Indo-1
ratio emphasizes this difference. Similar results were seen
in all six cells studied.
Discussion
The antiarrhythmic actions of n–3 PUFAs are well
documented: they inhibit various surface membrane ion
channels to reduce myocyte electrical excitability (Kang
et al. 1995) and, in addition, they inhibit the mechanism
responsible for spontaneous release of Ca2+ from the SR
(Negretti et al. 2000); Ca2+-induced Ca2+ release. Thus
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Figure 6. EPA shortens contraction even under
voltage clamp
Upper traces, averaged records (n = 10) of cell
shortening under voltage clamp. Lower traces, control
and EPA (5 μmol l−1; grey) contractions are shown
normalized for amplitude and superimposed.
spontaneous action potentials are less likely as they are
more difficult to stimulate and one of the triggers is less
frequent. However, as we show here, n–3 PUFAs also
have other effects that change the contractile behaviour
of the cardiac cell. These may be important for improving
diastolic function in ischaemic hearts and ensuring cells
can survive a period of ischaemia.
Throughout this study, EPA increases the rate of fall
of the Ca2+ transient and relaxation of contraction
(irrespective of the effect on Ca2+ transient and
contraction amplitudes). In intact hearts this is associated
with increased phosphorylation of phospholamban at the
PKA-specific site and increased PKA activity. Is there
any evidence that n–3 PUFAs activate PKA? In fact
the literature suggests the opposite; in vitro n–3 PUFAs
inhibit the PKA catalytic subunit (Mirnikjoo et al. 2001).
% Cell
Length
H89
EPA EPA
500 ms
0
10
A B
200 ms
Figure 7. The lusitropic effect of EPA is lost in the
presence of H89
A, averaged cell shortening records (n = 6) in control
conditions under field stimulation. B, averaged cell
shortening records (n = 6) in the presence of
10 μmol l−1 H89. A and B, the EPA (10 μmol l−1) trace
is shown in grey. The traces below in each panel show
normalized and superimposed contractions in control
and EPA.
However, there is also evidence that n–3 PUFAs inhibit
phosphodiesterase (Dubois et al. 1993; Picq et al. 1996)
and increase cAMP levels (Picq et al. 1996). Although
this should overcome some direct PKA inhibition, it
appears not to take place in our study where we find
cAMP levels actually fall. However, our measurements
show that 10 μmol l−1 EPA increases PKA activity (Fig. 3),
so how can this be explained? Recently it has been shown
that reactive oxygen species (ROS) can activate PKA by
forming a disulphide bridge between cysteine groups
linking regulatory subunits together, leading to activation
of the kinase (Brennan et al. 2006). Of course, for this to
be important here it is necessary that n–3 PUFAs lead to
production of ROS and indeed this is the case (Maziere
et al. 1999; Arita et al. 2001). Thus, perhaps by acting
on mitochondrial respiration, ROS are formed, PKA is
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activated and the changes of contractile behaviour we
report take place. ROS formation may also account for the
fall of [cAMP] in EPA as it is known that adenylate cyclase
is inhibited by ROS (Persad et al. 1998). Such a sequence
of events remains to be confirmed experimentally.
The remaining experiments in this study sought to
demonstrate a role for PKA in the positive lusitropic
effect of EPA. Phospholamban is an important PKA
target protein, and in Fig. 3B we show that EPA
increased phospholamban phosphorylation at Ser16 (the
PKA-specific site). This would contribute to the positive
lusitropic effect of EPA we report.
Phosphorylation of the L-type Ca2+ channel by PKA
increases its open probability (Brum et al. 1984) leading to
more current. However, EPA also inhibits the L-type Ca2+
channel (Xiao et al. 1997; Macleod et al. 1998; Negretti
et al. 2000). This inhibition might disguise the effect of
PKA on current amplitude. Our approach to this has been
to compare EPA-induced inhibition of L-type current in
control and with PKA inhibited. Inhibition of PKA should
leave only direct inhibition without any indirect increase
of current due to phosphorylation. One problem with this
is that H89 reduced L-type current (not shown) perhaps
due to loss of baseline phosphorylation of L-type channels
or direct inhibition of the channel as has been recently
shown in rat myocytes (Bracken et al. 2006). To allow us
to compare current inhibition, we raised bathing Ca2+ to
3 mmol l−1 (the inhibition of L-type current by EPA in
3 mmol l−1 Ca2+ is not significantly different from that in
1 mmol l−1 Ca2+; not shown). EPA inhibited about 40% of
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Figure 8. EPA reduces myofilament Ca2+ sensitivity
A, the upper traces show cell shortening records, below are Indo-1
ratio records. The bar indicates that external Na+ was reduced to 50%
of control solution concentration. B, the plot shows the relationship
between Indo-1 ratio and cell shortening in the absence (control; black
symbols) and in presence of EPA (grey symbols).
L-type current in control and over 60% with PKA inhibited
(Fig. 4), indicating an increase of L-type current through
PKA-dependent channel phosphorylation compensating
for some of the direct inhibition by EPA.
One possible complication for this experiment is the
selectivity of H89, as it also inhibits other kinases, e.g.
CaM kinase II. However, even at the relatively high
concentrations used here we would expect only minor
inhibition of this enzyme (Chijiwa et al. 1990). Similarly,
PK C is inhibited only slightly by 10 μmol l−1 H89 (Chijiwa
et al. 1990). It seems fair therefore to conclude that the
effects of EPA in H89 differ from those in the absence of
H89 due to inhibition of PKA. This also seems fair in the
light of the direct measurements of activation of PKA and
PKA-dependent phosphorylation (Fig. 3) we also report.
The evidence so far suggests PKA is activated in the
presence of EPA, why then, is the rate of decay of the
Ca2+ transient reduced in voltage clamp (Fig. 5) and
increased when the action potential stimulates contraction
(Fig. 2)? One obvious difference is that the Ca2+ transient
amplitude is reduced in voltage clamp, but increases in
current clamp (cf. Figs 5 and 2). Underlying this are
the electrophysiological effects of EPA. Under voltage
clamp, the negative inotropic effect follows inhibition
of L-type current whereas under current clamp the
longer action potential leads to a larger Ca2+ transient.
One consequence of a smaller Ca2+ transient would be
reduced activation of CaM kinase II, as less activating
Ca2+ would be bound to calmodulin. CaM kinase II
also phosphorylates phospholamban increasing SERCA
activity (Le Peuch et al. 1979). Here again, we have
two counteracting effects: increased PKA-dependent
phosphorylation of phospholamban and a probable
decrease of CaM-kinase-II-dependent phosphorylation.
In order to distinguish between these effects, we compared
the rate of decay of the Ca2+ transient over a range of
amplitudes. In this way we hoped to remove Ca2+ transient
amplitude as a variable. In Fig. 5B, we see that in
EPA the time constant of decay is smaller at all Ca2+
transient amplitudes, i.e. Ca2+ falls faster than in the
control. This shows the effect of EPA on PKA activity
without the confusing influence of altering Ca2+ transient
amplitude. The second approach we made to this question
was simply to inhibit PKA. As can also be seen in Fig. 5B,
in H89 there is almost complete overlap between the
points collected in the presence and absence of EPA.
Again, a resting level of PKA-dependent phosphorylation
is suggested by the upward shift of the curves in H89
in agreement with recent data in rat myocytes (Bracken
et al. 2006). We conclude therefore that the lack of a
positive lusitropic effect in EPA under voltage clamp,
e.g. in Fig. 5A, results from the smaller amplitude of
the Ca2+ transient under these conditions. As has been
shown earlier (Schouten, 1990; Bassani et al. 1995),
the smaller size of the transient reduces its rate of
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recovery, probably through the level of phosphorylation
of phospholamban at the CaM-kinase-II-specific site,
although CaM-kinase-II-independent mechanisms may
also exist (Valverde et al. 2005).
The final observation we make here relates to
myofilament Ca2+ sensitivity. EPA greatly reduces the
amount of cell shortening for a given rise of intra-
cellular Ca2+ (Fig. 8). This too, may result from
activation of PKA as phosphorylation of troponin I lowers
myofilament Ca2+ sensitivity (Zhang et al. 1995). Under
physiological conditions this helps allow faster relaxation
to accommodate higher frequencies during β-adrenergic
stimulation. Under ischaemic conditions, therefore, two
effects of n–3 PUFAs, i.e. the faster relaxation we report
here and the lower resting [Ca2+]i we have previously
reported (O’Neill et al. 2002), could combine to combat
diastolic dysfunction during myocardial ischaemia that
may develop due, for example, to loss of ATP and
consequent slowing of SERCA activity (Halow et al. 1999;
Overend et al. 2001).
The benefit of a positive lusitropic effect
Several lines of evidence presented here either suggest
(Figs 4, 5 and 7) or show directly (Fig. 3) that EPA causes
an activation of PKA. The resulting phosphorylations
lead to changes of the contractile properties of the
cells that may benefit ischaemic myocardium. The
rate of relaxation is increased in the presence of
EPA in intact hearts (Fig. 3) and isolated myocytes
(Fig. 1). Diastolic dysfunction is an early consequence of
myocardial ischaemia, a positive lusitropic effect would
benefit the heart by preserving pump function. In addition,
reduced myofilament Ca2+ sensitivity would limit energy
consumption thereby preserving ATP levels. This might
enable the cell to survive a period of ischaemia with less
damage. Evidence that reduced Ca2+ sensitivity of the
myofilaments might, indeed, be beneficial comes from a
study showing that an inhibitor of actin–myosin inter-
action, BDM, limits the infarct size following coronary
artery occlusion (Garcia-Dorado et al. 1992). It is also
worth noting that fish oil supplementation of the diet
leads to less ischaemic damage following coronary artery
ligation in rabbits (Ogita et al. 2003) and reduces the
fraction of isolated rat ventricular myocytes that die during
simulated ischaemia/reperfusion (Takeo et al. 1998).
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